Swedish Drug Discovery and Development Pipeline Report

On March 8, 2023 SwedenBIO launched the 2023 edition of the large, recurring mapping of the Swedish pharmaceutical pipeline.

The Swedish Drug Discovery and Development Pipeline Report 2023 contains a mapping of the pharmaceutical pipeline run by companies headquartered in Sweden. The target group for the report includes international investors, the life science industry in Sweden and of course decision makers within politics, business and academia. The aim of the report is to be a basis for fact-based improvements of the industry and to promote Sweden’s position in pharmaceutical development.

The report has been produced by SwedenBIO in cooperation with Citeline and Business Sweden, with support from Vinnova.

Video from the launch

Watch the broadcast from the launch of the report on 8 March 2023 from the studio of our member and launch partner, DNB. In the studio: Dr Maja Neiman, report editor and Science Relations Manager at SwedenBIO, Daniel Chancellor, Thought Leadership and Consulting Director at Citeline. SwedenBIO’s Director of Communications and International Marketing Alexandra Hoegberg is moderating the discussion.

Access the report

The full report package is provided here free-of-charge for downloading.

The report
Download the report, including data visualisations of key findings, feature articles, columns, highlights, and a methodology section.

The report appendix
The full lists of all 506 projects from the 159 companies covered in the report.

Company list 2023
An excel file that you can sort as you wish.

Project list 2023
An excel file that you can sort as you wish.